Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15408411> ?p ?o }
Showing triples 1 to 34 of
34
with 100 triples per page.
- Q15408411 subject Q8217320.
- Q15408411 abstract "Elinogrel (INN, USAN) was an experimental antiplatelet drug acting as a P2Y12 inhibitor. Similarly to ticagrelor and in contrast to clopidogrel, elinogrel was a reversible inhibitor that acted fast and short (for about 12 hours), and it was not a prodrug but pharmacologically active itself. The substance was used in form of its potassium salt, intravenously for acute treatment and orally for long-term treatment. Development was terminated in 2012.".
- Q15408411 atcPrefix "none".
- Q15408411 casNumber "936500-94-6".
- Q15408411 fdaUniiCode "915Y8E749J".
- Q15408411 iupacName "N-[(5-chlorothiophen-2-yl)sulfonyl]-N'-{4-[6-fluoro-7-(methylamino)-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl]phenyl}urea".
- Q15408411 pubchem "16066663".
- Q15408411 thumbnail Elinogrel_skeletal.svg?width=300.
- Q15408411 wikiPageWikiLink Q14916330.
- Q15408411 wikiPageWikiLink Q285166.
- Q15408411 wikiPageWikiLink Q30612.
- Q15408411 wikiPageWikiLink Q410237.
- Q15408411 wikiPageWikiLink Q420542.
- Q15408411 wikiPageWikiLink Q4926095.
- Q15408411 wikiPageWikiLink Q507154.
- Q15408411 wikiPageWikiLink Q603741.
- Q15408411 wikiPageWikiLink Q640448.
- Q15408411 wikiPageWikiLink Q703.
- Q15408411 wikiPageWikiLink Q721432.
- Q15408411 wikiPageWikiLink Q8217320.
- Q15408411 wikiPageWikiLink Q824258.
- Q15408411 atcPrefix "none".
- Q15408411 casNumber "936500".
- Q15408411 iupacName "N-[sulfonyl]-N'-{4-[6-fluoro-7--2,4-dioxo-1,4-dihydroquinazolin-3-yl]phenyl}urea".
- Q15408411 pubchem "16066663".
- Q15408411 unii "915".
- Q15408411 type ChemicalSubstance.
- Q15408411 type Drug.
- Q15408411 type ChemicalObject.
- Q15408411 type Thing.
- Q15408411 type Q8386.
- Q15408411 comment "Elinogrel (INN, USAN) was an experimental antiplatelet drug acting as a P2Y12 inhibitor. Similarly to ticagrelor and in contrast to clopidogrel, elinogrel was a reversible inhibitor that acted fast and short (for about 12 hours), and it was not a prodrug but pharmacologically active itself. The substance was used in form of its potassium salt, intravenously for acute treatment and orally for long-term treatment. Development was terminated in 2012.".
- Q15408411 label "Elinogrel".
- Q15408411 depiction Elinogrel_skeletal.svg.